KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Return on Sales (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Return on Sales for 7 consecutive years, with 0.03% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 1.0% to 0.03% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.04% through Dec 2025, up 2.0% year-over-year, with the annual reading at 0.04% for FY2025, 2.0% up from the prior year.
  • Return on Sales hit 0.03% in Q4 2025 for GoodRx Holdings, up from 0.01% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.31% in Q2 2023 to a low of 0.22% in Q3 2022.
  • Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.01% in 2025.
  • Biggest five-year swings in Return on Sales: soared 183bps in 2021 and later decreased -28bps in 2024.
  • Year by year, Return on Sales stood at 0.19% in 2021, then surged by 94bps to 0.01% in 2022, then plummeted by -1128bps to 0.13% in 2023, then surged by 126bps to 0.03% in 2024, then dropped by -18bps to 0.03% in 2025.
  • Business Quant data shows Return on Sales for GDRX at 0.03% in Q4 2025, 0.01% in Q3 2025, and 0.06% in Q2 2025.